Nancy Haverkos LPCC MA

Recommended Articles

• How is Bronchitis Treated?

  Bronchitis, the condition in which the bronchial tubes are inflamed, is classified into two main types – acute and chronic bronchitis. Acute bronchitis often goes away after one to two weeks, while chronic bronchitis may recur and remain for months on end. Viruses cause acute bronchitis, while...

• What Is Baby Acne?

  What is Baby Acne?Does your child have more pimples than those of an eighth grader? This pimply appearance of puberty is very common, often beginning at two to three weeks of age. It affects more than forty percent of all infants. Fortunately, it isn’t permanent and doesn’t cause any trouble to...

• Lupus Arthritis

  What is Lupus?Lupus, commonly known as Systemic Lupus Erythematosus (SLE) is a multisystemic autoimmune condition that affects almost all systems of the body. This could include the skin, eyes, joints, kidneys, lungs, and heart. The symptoms of each and every patient are going to be different. For...

• What Are the Symptoms of Ovarian Cancer?

  Abnormal growth and division of the cells in one or both the ovaries in women is referred to as ovarian cancer. The abnormal cells of this cancer are capable of invading other organs in the body, like the fallopian tubes and the uterus. The cells may break off from the main growth region and form...

• Parkinson's Disease Patients are Given Renewed Hope with a New Therapy

  Hitherto there is no truly preventive treatment for Parkinson’s disease. It is important that neurologists be aware of the symptomatic triad of depression, losing the sense of smell and constipation. It is good to consult with a neurologist with some expertise in the subject when these cases are...

• Breaking News on the Treatment of Follicular Lymphoma

  Reuters, the international news agency out of London, has announced that the FDA has given a new drug “accelerated approval,” for the treatment of follicular lymphoma.The drug, Aliqopa (copanlisib), showed complete or partial shrinkage of tumors in 59% of study participants during drug studies,...